Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · IEX Real-Time Price · USD
3.610
0.00 (0.00%)
At close: May 17, 2024, 4:00 PM
3.530
-0.080 (-2.22%)
After-hours: May 17, 2024, 6:42 PM EDT
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $197.79 million as of May 17, 2024. Its market cap has increased by 116.40% in one year.
Market Cap
197.79M
Enterprise Value
124.55M
1-Year Change
116.40%
Ranking
Category
Stock Price
$3.61
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $197.79M, a decrease of -45.83%. That is a compound annual growth rate of -19.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 197.20M | - |
| May 16, 2024 | 197.20M | -3.24% |
| May 15, 2024 | 203.80M | 4.78% |
| May 14, 2024 | 194.50M | 0.57% |
| May 13, 2024 | 193.40M | 7.92% |
| May 10, 2024 | 179.20M | -6.57% |
| May 9, 2024 | 191.80M | -1.94% |
| May 8, 2024 | 195.60M | 2.89% |
| May 7, 2024 | 190.10M | -6.95% |
| May 6, 2024 | 204.30M | 1.04% |
| May 3, 2024 | 202.20M | -3.11% |
| May 2, 2024 | 208.70M | 7.25% |
| May 1, 2024 | 194.60M | 12.68% |
| Apr 30, 2024 | 172.70M | -7.79% |
| Apr 29, 2024 | 187.30M | 6.36% |
| Apr 26, 2024 | 176.10M | -0.68% |
| Apr 25, 2024 | 177.30M | -6.09% |
| Apr 24, 2024 | 188.80M | -10.18% |
| Apr 23, 2024 | 210.20M | 6.70% |
| Apr 22, 2024 | 197.00M | 6.54% |
| Apr 19, 2024 | 184.90M | -5.23% |
| Apr 18, 2024 | 195.10M | -3.13% |
| Apr 17, 2024 | 201.40M | -5.71% |
| Apr 16, 2024 | 213.60M | -0.88% |
| Apr 15, 2024 | 215.50M | -6.35% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 202.74M |
| CervoMed | 201.06M |
| bluebird bio | 200.45M |
| Zevra Therapeutics | 200.06M |
| Lineage Cell Therapeutics | 199.18M |
| OrganiGram Holdings | 195.25M |
| Kodiak Sciences | 194.86M |
| Galectin Therapeutics | 193.76M |